The company
Moleculin Biotech, Inc.
MBRX · Nasdaq
MBRX stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 83.9% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 18 (-1)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Donald H. PickerChief Science Officer | bought | 173,333 | 3 Aug 2026filed 5 Aug 2026 |
| Donald H. PickerChief Science Officer | bought | 519,999 | 3 Aug 2026filed 5 Aug 2026 |
| Walter V. KlempCEO and President | bought | 533,333 | 3 Aug 2026filed 5 Aug 2026 |
| Jonathan P. FosterChief Financial Officer | bought | 293,333 | 3 Aug 2026filed 5 Aug 2026 |
| Jonathan P. FosterChief Financial Officer | bought | 879,999 | 3 Aug 2026filed 5 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 47,252$132K | +14,923+46.2% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 42,215$118K | +28,346+204.4% |
| VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026 | 29,883$83K | +23,811+392.1% |
| XTX Topco Ltdnew · filed 14 Aug 2026 | 22,942$64K | +22,942 |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 20,036$56K | +20,000+55555.6% |
| Rockefeller Capital Management L.P.added · filed 13 Aug 2026 | 15,000$42K | +10,579+239.3% |
| Tower Research Capital LLC (TRC)added · filed 11 Aug 2026 | 3,514$9,804 | +1,679+91.5% |
| CITIGROUP INCnew · filed 3 Aug 2026 | 2,674$7,460 | +2,674 |
| BARCLAYS PLCnew · filed 14 Aug 2026 | 621$1,733 | +621 |
| BlackRock, Inc.unchanged · filed 7 Aug 2026 | 491$1,370 | 00.0% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.